Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
24 Aug 2026, 2:00 pmDue today
GEM BID 09
9736422
GEM/2026/B/7900319
Two Packet Bid
Cilnidipine 10 mg plus Telmisartan 40 mg Tab,Cilnidipine 10 mg Tab,Cilnidipine 20 mg Tab,CILNIDIPIN
Bathinda, Punjab
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹64 L
₹3 Cr
40%
Exempted
Yes
13 Aug 2026
13 Aug 2026
24 Aug 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Cilnidipine 10 mg plus Telmisartan 40 mg Tab | 22,000 | No | [email protected] | 30 |
| 2 | Cilnidipine 10 mg Tab | 90,000 | No | [email protected] | 30 |
| 3 | Cilnidipine 20 mg Tab | 12,500 | No | [email protected] | 30 |
| 4 | CILNIDIPINE 5 MG TAB | 30,000 | No | [email protected] | 30 |
| 5 | Cilostazol 100mg Tab | 12,000 | No | [email protected] | 30 |
| 6 | Cilostazol 50mg Tab | 7,180 | No | [email protected] | 30 |
| 7 | Cinitapride 3 mg plus Panoprazole 40 mg Tab | 3,000 | No | [email protected] | 30 |
| 8 | Cinnarizine 25 mg Tab | 32,000 | No | [email protected] | 30 |
| 9 | Ciprofloxacin 500 mg plus Tinidazole 600 mg Tab | 10,800 | No | [email protected] | 30 |
| 10 | Ciprofloxacin 250 mg Tab | 6,150 | No | [email protected] | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9736422.pdf
GEM_BID • 1.06 MB
items_specification_bid_07-1_2026-08-10-19-05-37_3a66c430e80888efa817d7ea409fe199.pdf
BOQ • 2.28 MB
boq_item_sample_file-5_2026-08-10-19-05-37_165568d3e29b4e8f071764c60c155c8d.csv
BOQ • 0.02 MB
ATC_54f9c952-3b48-4d7e-929d1786423034568_niyamatsidhu.836y@gov.in.pdf
GEM_OTHER • 0.23 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].